BPQD@Fer-1 showed a trend toward longer median survival than free Fer-1 treatment, although the difference between these two groups did not reach statistical significance in the log-rank test ( Fig. 6 C).
← all excerpts
Ferrostatin-1-loaded black phosphorus quantum dots (BPQD@Fer-1) nanodelivery system attenuates T cell-mediated rejection after kidney transplantation.
2
—
—
The sentences
In contrast, at 37 °C (simulating the physiological reperfusion phase), the particle size remained stable for the first 24 h but showed a decreasing trend with broader distribution after 48 h, suggesting the gradual biodegradation of the BPQD framework.